Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (191-200 of 302) with videos related to

Pageof 31
Sort By:
Genes, Chromosomes & Cancer|June 15, 2010
High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genesK-John J Cheung, Allen Delaney, Susana Ben-Neriah, et al.
Plos One|August 15, 2009
Genetic variation in healthy oldest-oldJulius Halaschek-Wiener, Mahsa Amirabbasi-Beik, Nasim Monfared, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsJulie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
The Journal of Molecular Diagnostics : JMD|February 13, 2018
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma ManagementStacy S Hung, Barbara Meissner, Elizabeth A Chavez, et al.
British Journal of Haematology|January 30, 2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Andrew M Evens, Fangxin Hong, Leo I Gordon, et al.
Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Blood|June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOPLisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Pageof 31

Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Genes, Chromosomes & Cancer|June 15, 2010
High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genesK-John J Cheung, Allen Delaney, Susana Ben-Neriah, et al.
Plos One|August 15, 2009
Genetic variation in healthy oldest-oldJulius Halaschek-Wiener, Mahsa Amirabbasi-Beik, Nasim Monfared, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsJulie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
The Journal of Molecular Diagnostics : JMD|February 13, 2018
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma ManagementStacy S Hung, Barbara Meissner, Elizabeth A Chavez, et al.
British Journal of Haematology|January 30, 2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Andrew M Evens, Fangxin Hong, Leo I Gordon, et al.
Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.
British Journal of Haematology|October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphomaRichard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology|May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphomaKevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Blood|June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOPLisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Pageof 31